Teleflex (NYSE:TFX) Reaches New 12-Month Low - Time to Sell?

Shares of Teleflex Incorporated (NYSE:TFX - Get Free Report) hit a new 52-week low during trading on Friday . The company traded as low as $171.63 and last traded at $173.45, with a volume of 57596 shares traded. The stock had previously closed at $173.62.

Analysts Set New Price Targets

TFX has been the topic of a number of recent research reports. Mizuho dropped their price objective on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research note on Friday, November 1st. Truist Financial dropped their price objective on shares of Teleflex from $227.00 to $200.00 and set a "hold" rating on the stock in a research note on Wednesday, December 18th. Royal Bank of Canada dropped their price objective on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. StockNews.com raised shares of Teleflex from a "hold" rating to a "buy" rating in a research report on Thursday, November 28th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research report on Monday, December 16th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $252.50.

Teleflex Stock Performance

The company has a market cap of $7.95 billion, a PE ratio of 34.01, a PEG ratio of 1.72 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm's 50 day moving average is $179.58 and its 200-day moving average is $210.72.

Institutional Trading of Teleflex

Several large investors have recently bought and sold shares of TFX. GAMMA Investing LLC grew its stake in Teleflex by 131.1% during the 3rd quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company's stock valued at $42,000 after acquiring an additional 97 shares in the last quarter. Mather Group LLC. boosted its holdings in Teleflex by 180.8% in the 3rd quarter. Mather Group LLC. now owns 292 shares of the medical technology company's stock valued at $72,000 after purchasing an additional 188 shares during the last quarter. CWM LLC boosted its holdings in Teleflex by 170.2% in the 3rd quarter. CWM LLC now owns 3,559 shares of the medical technology company's stock valued at $880,000 after purchasing an additional 2,242 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in Teleflex by 200.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 300 shares of the medical technology company's stock valued at $74,000 after purchasing an additional 200 shares during the last quarter. Finally, Exchange Traded Concepts LLC acquired a new position in Teleflex in the 3rd quarter valued at about $61,000. Hedge funds and other institutional investors own 95.62% of the company's stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.